De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Astrana Health Toekomstige groei
Future criteriumcontroles 3/6
De verwachting is dat Astrana Health de winst en omzet met respectievelijk 18.7% en 16% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 17.1% per jaar.
Belangrijke informatie
18.7%
Groei van de winst
17.1%
Groei van de winst per aandeel
Healthcare winstgroei | 19.3% |
Inkomstengroei | 16.0% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Good |
Laatst bijgewerkt | 03 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce
Oct 04Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?
Sep 26Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business
Sep 12Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?
Aug 28Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors
Aug 02Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?
Jun 19Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal
Jun 02Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 09Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)
Apr 15At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?
Feb 25Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Feb 07Apollo Medical Holdings: Good Company, Not Quite A Hold
Jan 17With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For
Dec 27Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled
Nov 08Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?
Oct 26Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet
Sep 22Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down
Aug 04A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Jul 19We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt
Jun 19Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 05Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?
Apr 20Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Mar 21Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward
Jan 06Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Dec 16Apollo Medical to acquire Valley Oaks Medical Group
Oct 05Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan
Sep 26A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Sep 21The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising
Sep 06With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case
Aug 22Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 2,717 | 97 | N/A | 147 | 4 |
12/31/2025 | 2,267 | 80 | 84 | 106 | 8 |
12/31/2024 | 1,822 | 63 | 56 | 82 | 8 |
6/30/2024 | 1,592 | 68 | 50 | 64 | N/A |
3/31/2024 | 1,454 | 62 | 52 | 66 | N/A |
12/31/2023 | 1,387 | 61 | 40 | 68 | N/A |
9/30/2023 | 1,328 | 45 | 112 | 134 | N/A |
6/30/2023 | 1,297 | 46 | 61 | 83 | N/A |
3/31/2023 | 1,218 | 45 | 46 | 66 | N/A |
12/31/2022 | 1,144 | 45 | 59 | 82 | N/A |
9/30/2022 | 1,045 | 58 | -40 | -15 | N/A |
6/30/2022 | 955 | 69 | 41 | 72 | N/A |
3/31/2022 | 861 | 70 | 48 | 84 | N/A |
12/31/2021 | 774 | 69 | 51 | 70 | N/A |
9/30/2021 | 756 | 70 | 63 | 80 | N/A |
6/30/2021 | 709 | 53 | 57 | 65 | N/A |
3/31/2021 | 698 | 47 | 64 | 65 | N/A |
12/31/2020 | 687 | 38 | 45 | 46 | N/A |
9/30/2020 | 689 | 35 | 52 | 52 | N/A |
6/30/2020 | 665 | 22 | 47 | 48 | N/A |
3/31/2020 | 630 | 18 | 7 | 8 | N/A |
12/31/2019 | 561 | 14 | 13 | 14 | N/A |
9/30/2019 | 488 | 4 | 3 | 4 | N/A |
6/30/2019 | 499 | 10 | -11 | -10 | N/A |
3/31/2019 | 492 | 9 | 16 | 17 | N/A |
12/31/2018 | 520 | 11 | 24 | 25 | N/A |
9/30/2018 | 506 | 28 | 46 | 47 | N/A |
6/30/2018 | 436 | 24 | 39 | 41 | N/A |
3/31/2018 | 395 | 24 | N/A | 35 | N/A |
12/31/2017 | 356 | 26 | N/A | 52 | N/A |
9/30/2017 | 336 | 13 | N/A | 44 | N/A |
6/30/2017 | 323 | 11 | N/A | 45 | N/A |
3/31/2017 | 317 | 12 | N/A | 47 | N/A |
12/31/2016 | 306 | 11 | N/A | 22 | N/A |
12/31/2015 | 313 | 13 | N/A | 32 | N/A |
12/31/2014 | 134 | -1 | N/A | 16 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei ASTH ( 18.7% per jaar) ligt boven de spaarquote ( 2.5% ).
Winst versus markt: De winst van ASTH ( 18.7% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.2% per jaar).
Hoge groeiwinsten: De winst van ASTH zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van ASTH ( 16% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.7% per jaar).
Hoge groei-inkomsten: De omzet van ASTH ( 16% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van ASTH naar verwachting over 3 jaar hoog zal zijn